The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Sat., Sep. 19, 5:06 AM

Slide #7. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) 1 for 10 Reverse Split

Announced: 9/2/2020
Stock Split: 1 for 10
Record Date: 9/2/2020
Pay Date: 9/3/2020
SNSS Optionable?: Yes

Sunesis Pharmaceuticals is a biopharmaceutical company focused on the development of targeted inhibitors for the treatment of hematologic and solid cancers. Co.'s primary activities are conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology and conducting clinical trials. Co.'s primary program is vecabrutinib, a selective non-covalent inhibitor of Bruton's Tyrosine Kinase. Co. is also developing SNS-510, a phosphoinositide-dependent kinase-1 inhibitor licensed from Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited.
SNSS Detailed Information Page & Split History »

Company Name: 
Sunesis Pharmaceuticals Inc
Website: 
www.sunesis.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding SNSS: 
3
Total Market Value Held by ETFs: 
$6.15M
Total Market Capitalization: 
$26.00M
% of Market Cap. Held by ETFs: 
23.64%

Open the SNSS Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Hold (2.00 out of 4)
0th percentile
(ranked lower than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Splits Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.